logo
Darlington hospital drops in to help support the air ambulance - raising £10k

Darlington hospital drops in to help support the air ambulance - raising £10k

Yahoo19-05-2025

A CAMPAIGN by hospital staff to support the Great North Air Ambulance has really taken off.
Woodlands Hospital, in Darlington, chose the air ambulance as its charity of the year for 2024 and raised £10,720 with a range of activities, including sponsorship of the charity ball, and Easter and Christmas fundraising extravaganzas.
The cheque was handed over to the life-saving charity during a celebration day for its commercial partners.
Woodlands, part of Circle Health Group, is now one of GNAA's commercial partners, with the hospital's logo displayed on the back of a critical care response vehicle for a year.
(Image: Woodlands Hospital) The hospital's long-serving Executive Director, Debbie Dobbs, said: 'The Great North Air Ambulance carries out priceless work in our region and, as a hospital embedded in the local community, it is a charity which aligns with our own values.
(Image: Woodlands Hospital)Recommended reading:
Darlington dad praises building society for support of childhood cancer research
First look at £13m County Durham housing development creating 30 jobs
Concerns over Darlington's child poverty "shame" affecting hundreds of families
'Our staff really embraced the charity and we are all thrilled to have broken the £10,000 mark for such a great cause.'
During the celebration day, supporters were thanked by Dean Abbott, whose life was saved by the air ambulance after a motorcycle accident in August 2010.
The hospital staff have chosen St Teresa's Hospice as their charity for 2025.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NICE Recommends Earlier Treatments for Chronic Heart Failure
NICE Recommends Earlier Treatments for Chronic Heart Failure

Medscape

time31 minutes ago

  • Medscape

NICE Recommends Earlier Treatments for Chronic Heart Failure

Thousands of patients in England with early-stage chronic heart failure could benefit from earlier access to effective drug therapies under new draft guidance from the National Institute for Health and Care Excellence (NICE). The guidance, which updates NICE's 2018 clinical recommendations, advises earlier treatment for heart failure with reduced ejection fraction ( HFrEF). NICE said that clinical practice is changing and that medicines should be offered up to a year earlier in the treatment pathway. The changes could prevent 3000 deaths and 5500 hospital admissions annually in England, the regulator estimated. Earlier Use of Combination Therapies The four pillars of treatment for HFrEF include: Angiotensin-converting enzyme inhibitors (ACEIs) Beta-blockers (BBs) Mineralocorticoid receptor antagonists (MRAs) Sodium-glucose cotransporter-2 (SGLT2) inhibitors NICE said these drugs should be prescribed earlier, without the need to optimise the dose of any one medicine before introducing another. SGLT2 inhibitors such as empagliflozin and dapagliflozin should now be offered at the start of the treatment pathway, rather than after other medications have been fully titrated – a process that could take over a year. NICE also advised that angiotensin receptor neprilysin inhibitors (ARNIs) should be offered if a person cannot tolerate an ACEI, rather than only to patients stabilised on ACEIs or angiotensin receptor blockers (ARBs). Both SGLT2 inhibitors and ARNIs could now be initiated by GPs with advice from heart failure specialists, potentially speeding up patient access. Responding to Evolving Evidence 'We've been able to review the emerging evidence quickly to keep pace with changes in the treatment landscape and make recommendations that will widen access to effective treatments,' said Eric Power, deputy director in NICE's centre for guidelines. He added that the new approach could help reduce emergency hospital admissions and improve quality of life for people living with heart failure. Updated Diagnostic and Monitoring Advice NICE also updated guidance on diagnosis and monitoring, particularly for iron deficiency and anaemia in patients with HFrEF. Clinicians should: Assess iron status and check for anaemia using transferrin saturation (TSAT), serum ferritin, and haemoglobin Consider intravenous iron for patients with haemoglobin under 150 g/L and TSAT under 20% or ferritin under 100 ng/mL If iron deficiency anaemia is found, alternative causes beyond heart failure should be investigated. Revised Biomarker Recommendations In addition, NICE advised clinicians to be aware that: An NT-proBNP level of less than 400 nanogram per litre (47 pmol per litre) in an untreated person makes a diagnosis of heart failure less likely. The level of serum natriuretic peptide does not differentiate between heart failure with preserved, mildly reduced, and reduced ejection fraction. Obesity, African or African-Caribbean ethnic background, or treatment with a diuretic, an ACEI, an ARNI, an ARB, a beta-blocker, or a MRA could reduce serum natriuretic peptide levels. High levels of natriuretic peptides may also be caused by non-cardiac conditions such as COPD, diabetes, sepsis, and liver or kidney disease. Heart Failure Prevalence Almost one million people in the UK are currently living with heart failure, with 200,000 new diagnoses each year. The average age at diagnosis is 76. Rising life expectancy and obesity are driving the increased incidence and prevalence of the disease.

Napping Patterns Tied to All-Cause Mortality Risk
Napping Patterns Tied to All-Cause Mortality Risk

Medscape

time4 hours ago

  • Medscape

Napping Patterns Tied to All-Cause Mortality Risk

SEATTLE — Timing, duration, and variability of daytime napping are associated with an increased risk for mortality in middle- to older-aged adults, new research showed. An analysis of UK Biobank data, which included more than 86,000 non-shift workers, showed that longer naps, greater variability in daytime napping duration, and higher percentages of naps around noon and in the early afternoon are associated with an increased risk for all-cause mortality. 'Our study fills a gap in knowledge by showing that it's not just whether someone naps but how long, how variable, and when they nap may be meaningful indicators of future health risk,' lead investigator Chenlu Gao, PhD, with the Division of Sleep Medicine, Harvard Medical School and Massachusetts General Hospital in Boston, told Medscape Medical News . 'However, it's important to emphasize that these are associations. Because the design of this study is observational, we cannot determine whether napping patterns cause higher mortality risk or simply reflect underlying health conditions,' Gao cautioned. The findings will be presented on June 11 at SLEEP 2025. An Early Indicator of Declining Health? 'While many studies have examined the links between sleep and mortality, they have largely focused on nighttime sleep, often overlooking daytime sleep. However, napping is an important component of the 24-hour sleep-wake cycle and may carry its own health implications,' Gao explained. For the study, the researchers examined whether actigraphy-measured objective daytime napping behaviors predict all-cause mortality in 86,565 non-shift workers. The cohort had a mean age of 63 years at baseline, and 57% were women. They were monitored by actigraphy for 7 days, and daytime napping was defined as sleep between 9 AM and 7 PM. Median nap duration was 0.40 h/d, with 34% of naps taken between 9 and 11 AM, 10% between 11 AM and 1 PM, 14% between 1 and 3 PM, 19% between 3 and 5 PM, and 22% between 5 and 7 PM. During a follow-up period of up to 11 years, 5189 (6.0%) participants died. Overall, as individuals aged, naps tended to become longer and more irregular, with timing shifting toward the afternoon. After adjusting for potential confounders, including demographics, BMI, smoking, alcohol use, and nighttime sleep duration, longer nap duration was associated with an increased risk for mortality (hazard ratio [HR], 1.20 for 1 SD; P < .0001). Greater intraindividual variability (HR, 1.14 for 1 SD; P < .0001) and a higher percentage of naps between 11 AM and 1 PM (HR, 1.07 for 1 SD; P = .0005) and between 1 and 3 PM (HR, 1.07 for 1 SD; P = .0002) were also associated with an increased risk for mortality. 'These findings highlight the potential importance of considering napping behaviors in risk stratification of mortality in middle- to older-aged adults,' the researchers noted in their abstract. 'Longer or more irregular naps may reflect poor nighttime sleep, circadian rhythm disruption, or underlying health conditions such as cardiovascular disease, metabolic disorders, depression, or early neurodegenerative changes. Our findings suggest that certain patterns of napping could serve as early indicators of declining health,' said Gao. However, the researchers did not specifically test these mechanisms in this study, and further research is needed to clarify the biological pathways underlying these associations, Gao cautioned. Ask About Napping Commenting on the research for Medscape Medical News , James A. Rowley, MD, professor of medicine and program director, Sleep Medicine Fellowship, Rush University Medical Center in Chicago, said the 'major take-home message is that if physicians ask about a patient's sleep habits, they should also be asking about napping, not just the nocturnal sleep period. In other words, physicians should be asking their patients, 'do you nap during the day?'' 'One cannot ignore daytime napping and an evaluation for the etiology of daytime napping is important,' said Rowley. Rowley noted that the key questions to consider include whether the patient is obtaining sufficient nocturnal sleep. Could an underlying sleep disorder — such as sleep apnea or restless legs syndrome — be contributing? Might another medical condition, such as chronic heart failure or chronic obstructive pulmonary disease, be disrupting nighttime sleep and prompting daytime napping?

Residents at care home enjoy visit from 'therapeutic' alpacas
Residents at care home enjoy visit from 'therapeutic' alpacas

Yahoo

time5 hours ago

  • Yahoo

Residents at care home enjoy visit from 'therapeutic' alpacas

Residents at a Peterborough care home were surprised by a visit from some alpacas. The group of animals from Gorefield Alpacas spent the day at Longueville Court care home on May 28. The residents and their families spent the afternoon feeding the alpacas and learning about them. Longueville Court care home residents enjoy alpaca visit (Image: Longueville Court care home) General manager Krzysztof Krzysztofiak said: "Our residents have really enjoyed their unusual visitors today. "We knew that having Gorefield Alpacas here would be a bit of fun for all our residents, especially as some find it difficult to go on many outings in our minibus. "We are always looking for new activities for the residents and today we have seen the enjoyment and the therapeutic influence animals can have on people." Longueville Court care home residents enjoy alpaca visit (Image: Longueville Court care home) Teal Cunningham, a resident at the care home, said: "As a child I used to love all the animals on the nearby farm. "Today was very enjoyable, and it was wonderful that the animals were here and we got to feed them." Longueville Court care home provides residential care, nursing care and dementia care for 104 residents. Keep up to date with the latest news across Peterborough by signing up to our newsletter email alerts here Have you got a story you want to share with us? Get in touch at: news@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store